Roman Willi

4PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 10, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

Jutta Gärtner, Stephen L Hauser, Amit Bar-Or

|Mar 01, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.

Stephen L Hauser, Anne H Cross, Kevin Winthrop

|Nov 17, 2021
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.

Jun-Ichi Kira, Jin Nakahara, Denis V Sazonov

|Oct 04, 2021
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.

Amit Bar-Or, Heinz Wiendl, Xavier Montalban

Pageof 1

Frequent Collaborators

2 joint publications

Heinz Wiendl

2 joint publications

Stephen L Hauser

2 joint publications

Anne H Cross

2 joint publications

Ludwig Kappos